MONDAY, June 14, 2021 (HealthDay News) — Novavax, a Maryland biotechnology company that has struggled mightily with delays in developing its coronavirus vaccine, announced Monday that its two-shot regimen was over 90% effective overall in a trial that unfolded even as more contagious variants emerged. Among 30,000 volunteers — allContinue Reading
MONDAY, June 14, 2021 (HealthDay News) — British researchers report that babies have a strong immune response to the virus that causes COVID-19, based on a new, small study. For the research, the investigators assessed the immune systems of four infants under 3 months of age who had recovered fromContinue Reading
FRIDAY, June 11, 2021 (HealthDay News) — As the number of people fully immunized against COVID-19 rises into the hundreds of millions, immunologists and infectious disease experts now are pondering a new question in the unfolding pandemic. Namely, how long will vaccine immunity last, and will people who’ve gotten theContinue Reading
THURSDAY, June 10, 2021 (HealthDay News) — There’s more proof that getting a flu shot during pregnancy doesn’t pose a risk to children’s health. “This study adds to what we know from other recent studies showing no harmful effects of flu vaccination during pregnancy on the longer-term health of children,”Continue Reading
THURSDAY, June 10, 2021 (HealthDay News) — The coronavirus pandemic has affected American smokers in different ways, a new study finds. While some smoked more to help them cope with the crisis, others quit to reduce their COVID-19 infection risk. “Even before the pandemic, tobacco smoking was the leading preventableContinue Reading
WEDNESDAY, June 9, 2021 (HealthDay News) — After Texas relaxed COVID-19 restrictions, other respiratory illnesses — such as colds, bronchitis and pneumonia — made rapid rebounds. Pathologists from Houston Methodist Hospital found that the rhinovirus and enterovirus infections that can trigger these illnesses started rebounding in the fall of lastContinue Reading
TUESDAY, June 8, 2021 (HealthDay News) — A real-world study shows that even when folks who get the Pfizer and Moderna COVID-19 vaccines do have ‘breakthrough’ infections, those illnesses are mild. The study, from researchers at the U.S. Centers for Disease Control and Prevention, is among the first to showContinue Reading
TUESDAY, June 8, 2021 (HealthDay News) — New research suggests that many people who’ve undergone an organ transplant do not get an immune response from COVID-19 vaccines that’s strong enough to ward off a “breakthrough” infection. In a new review of 14 such cases, these breakthrough COVID-19 infections occurred inContinue Reading
MONDAY, June 7, 2021 (HealthDay News) — People hospitalized for COVID-19 are often discharged in much worse shape than before their illness — underscoring the value of preventing severe cases with vaccination. In a new study, researchers found that during the pandemic’s early months, almost half of COVID-19 patients dischargedContinue Reading
MONDAY, June 7, 2021 (HealthDay News) — It has been an elusive goal so far — finding a potent treatment that can beat back the new coronavirus before it grabs a hold of a patient’s immune system and sends it into overdrive. But new research suggests that more than aContinue Reading
FRIDAY, June 4, 2021 (HealthDay News) — In some good news for those who have already suffered through a bout of COVID-19, a new study finds they may have a much lower risk of reinfection for at least 10 months. For the study, the researchers analyzed rates of SARS-CoV-2 infectionsContinue Reading
WEDNESDAY, June 2, 2021 (HealthDay News) — Moderna plus Pfizer? J&J plus Moderna? There’s a new clinical trial underway to assess the safety and effectiveness of mixing different types of booster shots in adults who have been fully vaccinated against COVID-19. “Although the vaccines currently authorized by the U.S. FoodContinue Reading
TUESDAY, June 1, 2021 (HealthDay News) — COVID-19 does not pose a threat to the safety of the United States’ blood supply under existing donor screening guidelines, researchers report. For the study, the investigators reviewed the results of tests for the presence of SARS-CoV-2 in nearly 18,000 pools of donatedContinue Reading
FRIDAY, May 28, 2021 (HealthDay News) — Long-term data from northern Italy — an area hit hard during the early days of the pandemic — suggests that reinfection after recovery from COVID-19 infection is very rare, and immunity in former patients could be long-lasting. “Natural immunity to SARS-CoV-2 appears toContinue Reading